However, median SAA concentration and status of amyloid deposits varied substantially between individuals in these studies, possibly due to the differences in underlying diseases and anti-inflammatory treatment or comorbidities (obesity, diabetes, hypertension, tobacco consumption) that may influence SAA levels. Here, SAA1 is linked to obesity due to melanocortin 4 receptor deficiency.